Market Newsdesk

March 17, 2025 5:49 am

The Gross Law Firm Notifies Shareholders of Skyworks Solutions, Inc.(SWKS) of a Class Action Lawsuit and an Upcoming Deadline

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Skyworks Solutions, Inc. (NASDAQ: SWKS).

Shareholders who purchased shares of SWKS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD:
July 30, 2024 to February 5, 2025

ALLEGATIONS: According to the complaint, defendants provided investors with material information concerning Skyworks’ expected revenue for the fiscal year 2025. Defendants’ statements included, among other things, confidence in Skyworks’ ability to expand its mobile business and capitalize on its growth potential by investing in new technologies to diversify its portfolio of offerings. On February 5, 2025, after market close, Skyworks announced its financial results for the first quarter of fiscal year 2025 and provided lower-than anticipated revenue guidance for the second quarter of fiscal year 2025. The Company attributed its results and low guidance to a “competitive landscape” that had “intensified” in recent years. Following this news, the price of Skyworks’ common stock declined dramatically. From a closing market price of $87.08 per share on February 5, 2025, Skyworks’ stock price fell to $65.60 per share on February 6, 2025, a decline of over 24% in the span of just a single day.

DEADLINE: May 5, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/skyworks-solutions-inc-loss-submission-form/?id=136028&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of SWKS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is May 5, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-skyworks-solutions-incswks-of-a-class-action-lawsuit-and-an-upcoming-deadline-302402354.html

SOURCE The Gross Law Firm

March 17, 2025 5:49 am

The Gross Law Firm Notifies Innovative Industrial Properties, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – IIPR

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Innovative Industrial Properties, Inc. (NYSE: IIPR).

Shareholders who purchased shares of IIPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/innovative-industrial-properties-inc-loss-submission-form-2/?id=135997&from=4

CLASS PERIOD:
February 27, 2024 to December 19, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) IIPR was experiencing significant declines in rent and property-management fees in connection with certain customer leases; (ii) the foregoing would likely impair the Company’s ability to maintain funds from operations and revenue growth; (iii) accordingly, IIPR’s leasing operations were less profitable than the Company had represented to investors; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

DEADLINE: March 18, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/innovative-industrial-properties-inc-loss-submission-form-2/?id=135997&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of IIPR during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 18, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-innovative-industrial-properties-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline–iipr-302402330.html

SOURCE The Gross Law Firm

March 17, 2025 5:49 am

ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of ESSA Pharma Inc. (NASDAQ: EPIX).

Shareholders who purchased shares of EPIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD:
December 12, 2023 to October 31, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) masofaniten in combination with enzalutamide had no clear efficacy benefit over enzalutamide alone; (ii) accordingly, masofaniten in combination with enzalutamide was less effective in treating prostate cancer than defendants had led investors to believe; (iii) the M-E Combination Study, a monotherapy and combination therapy for the treatment of prostate cancer, was unlikely to meet its prespecified Phase 2 primary endpoint; (iv) accordingly, defendants had overstated masofaniten’s clinical, regulatory, and commercial prospects; and (v) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: March 25, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/essa-pharma-inc-loss-submission-form/?id=136001&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of EPIX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 25, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/essa-pharma-inc-class-action-the-gross-law-firm-reminds-essa-pharma-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-march-25-2025–epix-302402337.html

SOURCE The Gross Law Firm

March 17, 2025 5:49 am

The Gross Law Firm Reminds Quantum Computing Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 28, 2025 – QUBT

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Quantum Computing Inc. (NASDAQ: QUBT).

Shareholders who purchased shares of QUBT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/quantum-computing-inc-loss-submission-form/?id=136025&from=4

CLASS PERIOD:
March 30, 2020 to January 15, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) defendants overstated the capabilities of QCI’s quantum computing technologies, products, and/or services; (ii) defendants overstated the scope and nature of QCI’s relationship with NASA, as well as the scope and nature of QCI’s NASA-related contracts and/or subcontracts; (iii) defendants overstated QCI’s progress in developing a thin film lithium niobate, TFLN foundry, the scale of the purported TFLN foundry, and orders for the Company’s TFLN chips; (iv) QCI’s business dealings with Quad M and millionways both qualified as related party transactions; (v) accordingly, QCI’s revenues relied, at least in part, on undisclosed related party transactions; (vi) all the foregoing, once revealed, was likely to have a significant negative impact on QCI’s business and reputation; and (vii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: April 28, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/quantum-computing-inc-loss-submission-form/?id=136025&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of QUBT during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 28, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-quantum-computing-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-28-2025–qubt-302402343.html

SOURCE The Gross Law Firm

March 17, 2025 5:49 am

Crocs, Inc. Sued for Securities Law Violations – Contact The Gross Law Firm Before March 24, 2025 to Discuss Your Rights – CROX

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Crocs, Inc. (NASDAQ: CROX).

Shareholders who purchased shares of CROX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/crocs-inc-loss-submission-form/?id=135999&from=4

CLASS PERIOD:
November 3, 2022 to October 28, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the nature and sustainability of footwear brand, HEYDUDE’s revenue growth by concealing that 2022 revenue growth was driven, in large part, by the Company’s efforts to stock third-party wholesalers and retailers following the February 2022 acquisition of HEYDUDE; (2) as the Company’s retail partners began to destock this excess inventory, waning product demand further negatively impacted the Company’s financial results; and (3) as a result, defendants’ representations about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

DEADLINE: March 24, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/crocs-inc-loss-submission-form/?id=135999&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CROX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 24, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/crocs-inc-sued-for-securities-law-violations—contact-the-gross-law-firm-before-march-24-2025-to-discuss-your-rights–crox-302402244.html

SOURCE The Gross Law Firm

March 17, 2025 5:48 am

Class Action Filed Against Novo Nordisk A/S (NVO) – March 25, 2025 Deadline to Join – Contact The Gross Law Firm

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO).

Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/novo-nordisk-a-s-loss-submission-form/?id=136002&from=4

CLASS PERIOD:
November 2, 2022 to December 19, 2024

ALLEGATIONS: According to the complaint, on December 20, 2024, Novo issued a press release announcing the below-expected results of their “REDEFINE 1” trial, “a 68-week efficacy and safety trial investigating subcutaneous CagriSema.” The trial showed that patients treated with CagriSema exhibited weight loss of 22.7% after 68 weeks, well short of Novo’s targeted expectation of at least 25% weight loss. The press release further indicated that participant patients were permitted to modify their own dosage during the trial and, as a result, only 57.3% of patients treated with CagriSema were on the highest dosage contemplated by the study. Following this news, Novo’s stock price fell by $18.44 per share to close at $85.00 per share.

DEADLINE: March 25, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/novo-nordisk-a-s-loss-submission-form/?id=136002&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of NVO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 25, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/class-action-filed-against-novo-nordisk-as-nvo—march-25-2025-deadline-to-join–contact-the-gross-law-firm-302402338.html

SOURCE The Gross Law Firm

March 17, 2025 5:48 am

Investors in FMC Corporation Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights – FMC

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of FMC Corporation (NYSE: FMC).

Shareholders who purchased shares of FMC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD:
November 16, 2023 to February 4, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s channel management initiatives were not progressing as represented; (2) faced with pricing pressure, the Company had made the decision not to compete on prices and instead walk away from sales opportunities; (3) the Company had inflated inventory in the channels in “Latin America, including Brazil, Asia, including India, as well as Canada and Eastern Europe;” and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE: April 14, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/fmc-corporation-loss-submission-form/?id=136017&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of FMC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 14, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/investors-in-fmc-corporation-should-contact-the-gross-law-firm-before-april-14-2025-to-discuss-your-rights–fmc-302402364.html

SOURCE The Gross Law Firm

March 17, 2025 5:48 am

Block, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before March 18, 2025 to Discuss Your Rights – XYZ

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Block, Inc. (NYSE: XYZ).

Shareholders who purchased shares of XYZ during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/block-inc-loss-submission-form/?id=135996&from=4

CLASS PERIOD:
February 26, 2020 to April 30, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) Block had engaged in widespread and years-long compliance lapses at Square and Cash App, including by failing to conduct basic due diligence regarding its customers’ identities or the nature of customer transactions so as to prevent the platforms from being used for illegal or illicit activities; (b) Block had effectively created a haven for widespread illegal and illicit activities on its Square and Cash App platforms by imposing minimal obligations on customers seeking to open accounts, transact, and deposit or withdraw funds; encouraging the use of bitcoin; and pressuring the Company’s banking partners to forgo ordinary know your customer due diligence activities; (c) thousands of transactions on Square and Cash App were made in connection with a wide variety of illegal and illicit activities, including, inter alia, money laundering, child sexual abuse, sex trafficking, drug trafficking, terrorism financing, contract killings, and illicit payments to entities and persons subject to economic sanctions; (d) Block allowed its customers to withdraw funds even after the accounts had been flagged for potentially illegal or illicit activities; (e) Block customers could open up multiple accounts using fake identities in order to engage in illegal or illicit activities; (e) Block customers could open up multiple accounts using fake identities in order to engage in illegal or illicit activities; (f) Block’s senior leadership and the Board had failed to correct identified compliance deficiencies despite numerous red flags, internal employee reports of deficiencies, and customer complaints; (g) Block’s Cash App user metrics had been artificially inflated through the use of fake accounts and the ability of criminals and other bad actors to open multiple accounts; and (h), as a result of (a)-(g) above, Block was subject to a material, undisclosed risk of its conduct being exposed, thereby exposing the Company to reputational harm, adverse regulatory actions, the loss of business activity, and adverse impacts to the Company’s operations and financial results.

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of XYZ during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 18, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/block-inc-sued-for-securities-law-violations–investors-should-contact-the-gross-law-firm-before-march-18-2025-to-discuss-your-rights–xyz-302402320.html

SOURCE The Gross Law Firm

March 17, 2025 5:48 am

The Gross Law Firm Reminds GSK plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 – GSK

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK).

Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD:
February 5, 2020 to August 14, 2022

ALLEGATIONS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market “[b]ased on information available at the time and correspondence with regulators.” GSK also stated that it was “continuing with investigations into the potential source of NDMA.” Defendants also assured investors that “GSK, the FDA, and the EMA [European Medicines Agency] have all independently concluded that there is no evidence of a causal association between ranitidine therapy and the development of cancer in patients,” findings that were “consistent with other ranitidine data published prior to 2019.” Finally, defendants claimed that they could not “quantify or reliably estimate the liability.” These representations were materially false or misleading. In truth, GSK was fully aware of the source of NDMA and had been for nearly 40 years before withdrawing Zantac from the market.

DEADLINE: April 7, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/gsk-loss-submission-form/?id=136012&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of GSK during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 7, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-gsk-plc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-7-2025–gsk-302402322.html

SOURCE The Gross Law Firm

March 17, 2025 5:48 am

TELUS International (Cda) Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – TIXT

PR Newswire

NEW YORK
, March 17, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of TELUS International (Cda) Inc. (NYSE: TIXT).

Shareholders who purchased shares of TIXT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/telus-international-loss-submission-form/?id=136006&from=4

CLASS PERIOD:
February 16, 2023 to August 1, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s AI Data Solutions offerings required the cannibalization of its higher-margin offerings; (2) Telus International’s declining profitability was tied to the Company’s drive to develop AI capabilities; (3) Telus International’s shift toward AI put greater pressure on the Company’s margins than previously disclosed; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE: March 31, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/telus-international-loss-submission-form/?id=136006&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TIXT during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 31, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/telus-international-cda-inc-sued-for-securities-law-violations–investors-should-contact-the-gross-law-firm-for-more-information–tixt-302402233.html

SOURCE The Gross Law Firm